Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 17-(cyclobutylmethyl)morphinan-3,14-diol
2. Apo-butorphanol
3. Bc 2627
4. Bc-2627
5. Bc2627
6. Beforal
7. Butorphanol
8. Butorphanol Tartrate
9. Dolorex
10. Moradol
11. Stadol
12. Stadol Ns
13. Torbugesic
1. Butorphanol Tartrate
2. 58786-99-5
3. Butorphanol (+)-tartrate Salt
4. Stadol (tn)
5. Butorphanol Tartrate Salt
6. Butorphanol Tartrate (jan/usp)
7. Akos015994595
8. Hs-0001
9. Butorphanol (+)-tartrate Salt, >=99%
10. D00837
11. 786b995
12. Butorphanol Tartrate, United States Pharmacopeia (usp) Reference Standard
1. Butorfanol
2. Torate
3. Torbutrol
| Molecular Weight | 477.5 g/mol |
|---|---|
| Molecular Formula | C25H35NO8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | 477.23626707 g/mol |
| Monoisotopic Mass | 477.23626707 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
| 2 of 2 | |
|---|---|
| Drug Name | Butorphanol tartrate |
| Drug Label | Butorphanol tartrate is a synthetically derived opioid agonist-antagonist analgesic of the phenanthrene series. The chemical name is (-)-17-(cyclobutylmethyl) morphinan-3, 14-diol [S-(R*,R*)] 2,3 dihydroxybutanedioate (1:1) (salt). The molecul... |
| Active Ingredient | Butorphanol tartrate |
| Dosage Form | Injectable; Spray, metered |
| Route | Nasal; Injection |
| Strength | 2mg/ml; 1mg/ml; 1mg/spray |
| Market Status | Prescription |
| Company | Bedford; Hikma Farmaceutica; Novex; Mylan; Roxane |
Antitussive Agents
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally. (See all compounds classified as Antitussive Agents.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotic Antagonists
Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
About the Company : Malladi Drugs & Pharmaceuticals Ltd, founded in 1980 by Mr. M L N Sastry, is a leader in manufacturing ephedrine and pseudoephedrine salts. It is now the top API manufacturer in th...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...

About the Company : We can help your company solve the payment problems during the trading from chinese factories. We supply you with OEM from china.We are professsionals with the competitive price an...

About the Company : Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to thePharmaceutical, Crop Protecti...

About the Company : TBD Pharmatech (formerly TBD-Biodiscovery) specializes in Active Pharmaceutical Ingredients (API), advanced intermediates, and the development and production of fine chemicals. It ...

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of Butorphanol Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Butorphanol Tartrate manufacturer or Butorphanol Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Butorphanol Tartrate manufacturer or Butorphanol Tartrate supplier.
A Stadol NS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stadol NS, including repackagers and relabelers. The FDA regulates Stadol NS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stadol NS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Stadol NS manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Stadol NS supplier is an individual or a company that provides Stadol NS active pharmaceutical ingredient (API) or Stadol NS finished formulations upon request. The Stadol NS suppliers may include Stadol NS API manufacturers, exporters, distributors and traders.
click here to find a list of Stadol NS suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Stadol NS DMF (Drug Master File) is a document detailing the whole manufacturing process of Stadol NS active pharmaceutical ingredient (API) in detail. Different forms of Stadol NS DMFs exist exist since differing nations have different regulations, such as Stadol NS USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Stadol NS DMF submitted to regulatory agencies in the US is known as a USDMF. Stadol NS USDMF includes data on Stadol NS's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stadol NS USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Stadol NS suppliers with USDMF on PharmaCompass.
A Stadol NS written confirmation (Stadol NS WC) is an official document issued by a regulatory agency to a Stadol NS manufacturer, verifying that the manufacturing facility of a Stadol NS active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Stadol NS APIs or Stadol NS finished pharmaceutical products to another nation, regulatory agencies frequently require a Stadol NS WC (written confirmation) as part of the regulatory process.
click here to find a list of Stadol NS suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stadol NS as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Stadol NS API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Stadol NS as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Stadol NS and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stadol NS NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Stadol NS suppliers with NDC on PharmaCompass.
Stadol NS Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Stadol NS GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Stadol NS GMP manufacturer or Stadol NS GMP API supplier for your needs.
A Stadol NS CoA (Certificate of Analysis) is a formal document that attests to Stadol NS's compliance with Stadol NS specifications and serves as a tool for batch-level quality control.
Stadol NS CoA mostly includes findings from lab analyses of a specific batch. For each Stadol NS CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Stadol NS may be tested according to a variety of international standards, such as European Pharmacopoeia (Stadol NS EP), Stadol NS JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stadol NS USP).